|
Expression of important laboratory findings |
||||||||
| Variable |
Day 1 |
Day 5 |
Day 10 |
Day 15 |
Day 25 |
Day 50 |
12 month |
Normal range |
|
|
||||||||
| IgG anti-cardiolipin antibody (GPL-U/ml) |
44.7 |
21 |
60.2 |
30.7 |
37.7 |
<12 |
||
| Lupus anticoagulant |
positive |
positive |
positive |
positive |
positive |
absent |
||
| Anti-β-2-Glycoprotein 1 (U/ml) |
2 |
6 |
3 |
negative |
<5 |
|||
| Anti-Phosphatidylserin (U/ml) |
72.8 |
10.8 |
31.1 |
<15 |
||||
| Anti-Phosphatidylethanolamin (U/ml) |
45.2 |
23.9 |
18.5 |
<15 |
||||
| Antinuclear antibodies |
negative |
negative |
absent |
|||||
| ENA |
negative |
absent |
||||||
| Double strand-DNA |
negative |
absent |
||||||
| anti-adrenal-antibodies |
negative |
absent |
||||||
| Cortisol 0800 h |
26 |
1.1 |
22 |
28 |
6–26 |
|||
| Renin activity |
100 |
<3β |
||||||
| ACTH (pg/ml) |
468 |
<50 |
||||||
| Aldosteron (pg/l) |
<10 |
12–125 |
||||||
| DHEA-sulfate (g/dl) |
<10 |
<280 |
||||||
| Bleeding time (min) |
10.55 |
5.30 |
<7 |
|||||
| Partial thromboplastin time (s) |
39 |
37 |
48 |
57 |
58 |
36 |
41 |
<35 |
| Prothrombin time (%) |
64 |
55 |
55 |
73 |
78 |
45 |
36 |
70–100 |
| Sodium (mmol/l) |
134 |
140 |
111 |
139 |
142 |
143 |
136 |
132–145 |
| Potassium (mmol/l) |
3.9 |
4.8 |
3.6 |
4.2 |
4.0 |
3.5 |
3.9 |
3.1–5.1 |
| C-reactive Protein (mg/dl) |
6.1 |
6.1 |
12.1 |
3.7 |
1.0 |
0.4 |
0.3 |
<0.5 |
| Aspartate aminotransferase (U/l) |
15 |
17 |
81 |
37 |
21 |
16 |
18 |
<15 |
| Alanine aminotransferase (U/l) |
20 |
18 |
67 |
69 |
40 |
24 |
22 |
<14 |
| LDH (U/l) |
201 |
442 |
309 |
256 |
181 |
<240 |
||
| Creatinine (mg/dl) |
0.7 |
0.7 |
1.0 |
0.7 |
0.8 |
0.93 |
0.3 |
0.6–1.3 |
| β2-microglobulin (mg/dl) |
0.18 |
0.27 |
0.19 |
<0.08 |
||||
| Hemoglobin (g/l) |
13.6 |
11.1 |
7.6 |
10.8 |
11.8 |
12.1 |
12.4 |
11.8–16.8 |
| Platelet count /nl |
129 |
177 |
56 |
154 |
97 |
153 |
174 |
150–350 |
| White cell count /nl |
14.5 |
10.3 |
10.2 |
6.2 |
5.4 |
5.6 |
7.8 |
4.3–10.0 |
Gerner et al. Thrombosis Journal 2005 3:6 doi:10.1186/1477-9560-3-6 |
||||||||